A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

September 19, 2008

Why Some Primates Aren’t Vulnerable to SIV

Scientists have discovered key biological differences that may explain why some primates don’t get sick despite being infected with simian immunodeficiency virus (SIV)—a virus almost identical to HIV—according to a Nature Medicine study reported by Science Daily.

As with primates—like chimpanzees and monkeys—and humans, SIV and HIV are genetically very similar. Therefore, by studying the effects of SIV in primates, scientists can learn about HIV and its possible prevention and treatment. For 20 years scientists have known that some SIV-infected primates don’t experience destruction of their immune systems, even though they have high amounts of the virus in their blood. Until now, however, the exact mechanism that allows some primates to remain well despite infection hasn’t been identified.

Mark Feinberg, MD, PhD, formerly of Emory University in Atlanta and now with Merck & Co, and his colleagues studied the activity of a variety of immune system cells in primates that do become ill from SIV, like Rhesus Macaques, and primates that do not, such as Sooty Mangabeys.

Dr. Feinberg’s team found that in SIV-infected Rhesus Macaques, the dendritic cells—immune cells responsible for identifying new infections and mounting an immune response—easily recognize SIV and mount a significant immune response. This is much the way humans respond to HIV.

The dendritic cells in Sooty Mangabeys, on the other hand, have little reaction to the presence of SIV. This blunted immune response is actually a benefit, as it prevents immune cells from being chronically activated, a process that many scientists now believe is responsible for the eventual destruction of the immune system. Thus, Sooty Mangabeys do become infected with SIV, and the virus actively reproduces in their bodies, but they don’t experience disease progression.

Feinberg’s team writes that their study reveals “a great deal about the emergence of the AIDS pandemic, and about the mechanisms underlying AIDS progression in humans. In addition, such insights will hopefully help inform new approaches to treat HIV infection most effectively.”

Search: Rhesus Macaques, Sooty Mangabeys, dendritic cells, immune activation, Mark Feinberg, Emory Univesity, Merck


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    adoniz89
    san dimas
    California


    UPPinAction
    New Brunswick
    New Jersey


    FoxyFresh57
    Bronx
    New York


    cme_jamesd
    Huntington Beach
    California
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.